BIRIKTIRUVCHI TO’QIMA DIFFERENTSIALLASHMAGAN DISPLAZIYASI BOR BEMORLARDA TO’QIMA REMODELLASHTIRISH HOLATINI BAHOLASН

##article.authors##

  • Gulandom Zikriyaevna Shodikulova
  • Zarrina Baxtiyarovna Babamuradova
  • Ozod Voxidovich Mirzaev

##article.subject##:

Biriktiruvchi to'qima differentsiyalanmagan displaziyasi, metalloproteinazlar, metalloproteinazalarning to'qima ingibitorlari, magniy ionlari (Mg 2)

##article.abstract##

Biriktiruvchi to'qima differentsiyalanmagan displaziyasi (BTDD) - turli xil klinik ko'rinishlar bilan ajralib turadigan har xil sindromlar va fenotiplarni o'z ichiga oladi. Ushbu ishning maqsadi 2.9 – turdagi matriksli metalloproteinazalarning (MMP-2,-9) ekspressiyasi, matriksli metalloproteinazalarning to'qima ingibitorlari (TIMP) va ularning magniy ionlari (Mg + 2) bilan o'zaro bog'liqligini, BTDD bemorlarning qondagi glikozaminoglikan va glyukuronidaza faolligini aniqlash uchun taqqoslama tekshiruvni o’tkazish. 15 yoshdan 25 yoshgacha (19,9 ± 1,42) bo’lgan 208 ta bemor tekshiruvdan o'tkazildi. Klinik belgilar va rivojlangan asoratlarga qarab, bemorlar 2 guruhga bo'lingan, 1-guruh - 97 BTDD ning tashqi fenotiplar (fenlari) belgilari bo'lgan bemorlar, 2-guruhi - ayrim asoratlari bilan tashqi va ichki fenlarning belgilariga ega bo'lgan 111 ta bemor. Tadqiqotlar shuni ko'rsatdiki, BTDD bilan kasallangan bemorlarning qonida MMP-2 va MMP-9 ning ko'payishi va TIMP-1ning pasayishi qayd etilgan. Kasallikning avj olib borishi bilan MMP-2 va MMP-9 ekspressiyasi kuchayadi va TIMP-1 nazorat ma'lumotlariga nisbatan kamayadi. Shu bilan birga, bemorlarda Mg + 2 ionlarining qonida pasayish kuzatiladi. Shunday qilib, BTDD bilan og'rigan bemorlarda MMP-2 va MMP-9, shuningdek TIMP-1 ekspressiyasidagi o'zgarishlarning dinamikasi patologik jarayonning rivojlanishini va kasallikning prognozini baholash uchun xizmat qilishi mumkin.

Библиографические ссылки

Altura B.M. Basic biochemistry and physiology of magnesiym; A brief reviem // Magnesium and Frace Elements.- 2011.- Vol.10.- P.167–171.

Babamuradova Z.B. Значение фенотипических, генетических маркеров на развитие, течение и раннюю диагностику недифференцированной дисплазии соединительной ткани // PhD dissertatsiya. – 2020. – 15-20 bet.

Babamuradova Z.B., Shodikulova G.Z., Mirzaev O.V. Treatment of patients with undifferentiated connective tissue dysplasia in mitral valve prolapse with varying degrees of mitral regurgitacion // European Science Review – Vena, 2018. – Volume 3-4, March-April. – Р.140-143

Bobkowski W., Nowak A., Durlach J. The importance of magnesium status in the pathophysiology of mitral valve prolapsed //Magnes. Res.- 2005.- Vol.18 (1).- P.35-52.

Cauwe B., Van den Steen P.E., Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases //Crit. Rev. Biochem. Mol. Biol.- 2007.- Vol.42(3).- P.113–185.

Chubanov V., Waldegger S., Mederos Y. et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia //Proc. Natl. Acad. Sci. USA.- 2004.- Vol.101(9).- P.2894–2899.

Feng W., Benz F.W., Cai J. et al. Metallothionein disulfides are present in metallothionein–overexpressing transgenic mouse heart and increase under conditions of oxidative stress //J. Biol. Chem.- 2006.- Vol.281(2).- P.681–687.

Guo H., Lee J.D., Uzui H. et al. Effects of folic acid and magnesium on the production of homocysteine–induced extracellular matrix metalloproteinase–2 in cultured rat vascular smooth muscle cells //Circ. J.- 2006.- Vol.70(1).- P.141–146.

Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview //Front. Biosci.- 2006.- Vol.11.- P.1696–1701.

Pages N., Gogly B., Godeau G. et al. Structural alterations of the vascular wall in magnesium–deficient mice. A possible role of gelatinases A (MMP–2) and B (MMP–9) //Magnes Res.- 2003.- Vol.16(1).- P.43–48.

Shodikulova G.Z., Babamuradova Z.B., Toirov E.S. Clinical biochemical features in patients witch undifferentiated connective tissue dysplasia // European Science Review – Vena, 2016. – Volume 1, May. – Р.129-131.

Shodikulova G.Z., Babamuradova Z.B., Occurrence of clinical options of undifferentiated connective tissue dysplasia in uzbek population// International Journal of Psychosocial Rehabilitation. Volume 24-Issue 2.

Shodikulova G.Z., Babamuradova Z.B., Mirzaev O.V., Assessment of extracellular matrix condition in persons with undifferentiated connective tissue dysplasia// International Journal of Pharmaceutical Research. Volume 12-Issue

Shodikulova G.Z., Mirzaev O.V., Babamuradova Z.B. Prevalence of clinical options of undifferentiated connective tissue dysplasia in uzbek population// LXIV international correspondence scientific and practical conference “EUROPEAN RESEARCH: innovation in science, education and technology”/ - London, United Kingdom, 2020. - Р. 90-92

Tani C., Carli L., Vagnani S. et al. The diagnosis and classification of mixed connective tissue disease // J. Autoimmun. 2014. Vol. 48-49. Р. 46-49

Загрузки

##submissions.published##

2021-02-26